生物活性 靶点 体外研究 体内研究 反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑 试剂级价格
ChemicalBook  CAS数据库列表  反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑

反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑

反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑,193551-21-2,结构式
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑
  • CAS号:193551-21-2
  • 英文名:SB 239063
  • 中文名:反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑
  • CBNumber:CB6100319
  • 分子式:C20H21FN4O2
  • 分子量:368.4
  • MOL File:193551-21-2.mol
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑化学性质
  • 熔点 :206-207.2 °C
  • 储存条件 :2-8°C
  • 溶解度 :DMSO: 11 mg/mL
  • 形态 :White solid
  • 颜色 :white
  • InChIKey :ZQUSFAUAYSEREK-WKILWMFISA-N
安全信息
  • 安全说明 :22-24/25
  • WGK Germany :3
  • RTECS号 :GV9458000
  • 海关编码 :2933599590

反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑性质、用途与生产工艺

  • 生物活性 SB239063是一种有效的选择性p38 MAPKα/β抑制剂,IC50为44 nM,对γ- 和 δ-激酶亚型没有活性。
  • 靶点
    TargetValue
    p38α
    (Cell-free assay)
    44 nM
    p38β
    (Cell-free assay)
    44 nM
  • 体外研究

    SB 239063 (0.1–10 μM ; 29 hours, 47 hours) increases apoptosis of eosinophils in a dose-related in the presence of 10 pM IL-5 at every time point from 21 hours onwards.
    SB 239063 potently inhibits IL-1 and TNF- a production in LPS-stimulated human peripheral blood monocytes with IC 50 values of 120 nM and 350 nM, respectively.

    Apoptosis Analysis

    Cell Line: Eosinophils (guinea pig BALs)
    Concentration: 0.1μM, 1μM, 10μM
    Incubation Time: 29 hours, 47 hours
    Result: Increased apoptosis of eosinophils in a dose-related in the presence of 10 pM IL-5 at every time point from 21 hours onwards.
  • 体内研究

    SB 239063 (12 mg/kg; p.o.; 1 hour before and 4 hours after OA challenge; b.i.d. for 3 days) significantly inhibits the resultant antigen-induced airway eosinophilia.
    SB 239063 (12 mg/kg; p.o.) almost abolishes ovalbumin (OA)-induced airway eosinophilia (~ 93% inhibition) by inhalation.
    SB 239063 is a potent inhibitor of LPS-induced TNF-alpha production in the mouse peritoneal cavity with an EC 50 of 5.8 mg/kg (2.8–10.3; 95% CL).

    Animal Model: Male BALB/c mice (18–20 g)
    Dosage: 12 mg/kg
    Administration: Oral administration; 1 h before and 4 h after OA challenge; bis in die for 3 days
    Result: Significantly inhibited the resultant antigen-induced airway eosinophilia.
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑上下游产品信息
上游原料
下游产品
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑 试剂级价格
  • 更新日期:2024/11/08
  • 产品编号:HY-11068
  • 产品名称:反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑 SB 239063
  • CAS编号:193551-21-2
  • 包装:1mg
  • 价格:500元
  • 更新日期:2024/11/08
  • 产品编号:HY-11068
  • 产品名称:反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑 SB 239063
  • CAS编号:193551-21-2
  • 包装:10mM * 1mLin DMSO
  • 价格:892元
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑生产厂家
  • 公司名称:Carbosynth
  • 联系电话:--
  • 电子邮件:sales@carbosynth.com
  • 国家:英国
  • 产品数:6005
  • 优势度:58
  • 公司名称:TOCRIS-US
  • 联系电话:--
  • 电子邮件:customerservice@tocris.co.uk
  • 国家:英国
  • 产品数:5726
  • 优势度:77
193551-21-2, 反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑相关搜索: